April 1, 2008

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

.   .   

Related Articles:

Internal Medicine for Nephrologists

Comments are closed.